Summary. The case of a female patient with fasting hypoglycaemia before the development of Type 1 (insulin-dependent) diabetes mellitus is reported. She presented with primary hypothyroidism, partial hypopituitarism, adrenal insufficiency and glucagon deficiency. Thyroid microsomal and gastric parietal cell antibodies were detected as well as HLA-B8, whereas islet cell antibodies were not demonstrable, even 2 years after the onset of diabetes. Plasma chromatography revealed true pancreatic glucagon (IRG 35~176 close to undetectable in basal samples with a questionable increase from 3 to 18 pg/ml during insulin-induced hypoglycaemia. After an overnight fast, moderate hyperaminoacidaemia was found with elevations of alanine, glycine, serine, arginine and ornithine as seen in pancreatectomized patients. It is suggested that the deficient glucagon secretion in this patient might, at least in part, have been the cause of fasting hypoglycaemia and the failure of glucose recovery following insulin-induced hypoglycaemia. Possibly, the A cell deficiency was part of the polyglandular failure syndrome in this patient.
The high prevalence of diabetes mellitus in patients with thyroid and adrenal insufficiency (Schmidt's syndrome) has been reported in detail [1] [2] [3] [4] . The detection of autoantibodies and certain histocompatibility leucocyte antigens in these patients indicates that the polyglandular failure syndrome may be due to autoimmune processes [5] [6] [7] . Evidence of inappropriate glucagon secretion in patients with the polyglandular failure syndrome has hitherto not been reported. Vidnas et al. [8] reported the first case of isolated congenital glucagon deficiency causing severe neonatal hypoglycaemia. Earlier reports of glucagon deficiency were based upon histological evidence of reduced A cells and not verified by simultaneous glucagon measurements [9] . The fundamental role of glucagon in glucose recovery from insulin-induced hypoglycaemia has been assessed in studies with pharmacological inhibition of glucagon [10] but glucagon deficiency has not been verified by chromatography.
Subject and Methods

Patient
A 27-year-old female patient with fasting hypoglycaemia (<2 mmol/1) was referred to our metabolic ward in 1979 for suspected insulinoma. There was no family history of endocrinopathies. Before admission several episodes of hypoglycaemia occurred during food deprivation due to toothache. Besides a homogeneously enlarged thyroid gland, no clinical abnormalities were found. We had the opportunity to see the patient repeatedly over a period of 2.5 years.
Hormones were assayed with standard radioimmunological techniques using commercial kits. Plasma glucagon (IRG) was measured with the specific antibody 30K as described previously [11] . Standard diagnostic tests for evaluating disorders of the endocrine system were used and were performed before any replacement therapy [12] . Tests were carried out using: ACTH (0.25 mg tetracosactid IV; Synacthen, Ciba-Geigy, Wehr/Baden, FRG); vasopressin (5 IU ornipressin IV/ 30min; POR8 Sandoz, Ntirnberg, FRG; TRH (400]xg synthetic TRH'IV); and LH-RH (100~tg synthetic LH-RH'IV; Relefact, Hoechst, Frankfurt, FRG). Serum amino acids were assayed using a Biotronik analyzer (Biotronik, Frankfurt, FRG) [13] . HLA-typing was performed by standard microlymphotoxity testing. The technique of autoantibody determination has been described in detail [3] . Reference data of normal subjects were available for arginine-infusions (n =20), insulin tolerance tests (n = 15) and glucagon chromatography (n = 18).
Glucagon Chromatography [14] Plasma samples (2.4-3.0 ml) obtained before and after insulin and arginine administration were loaded on 40 x I cm Biogel P30 columns (Biorad Laboratories, Richmond, California, USA). Variations in the values of total IRG in plasma samples and chromatography are due to the use of different batches of the 30K antiserum reacting different- ly with big plasma glucagon. 125I-insulin and 12SI-glucagon were used as molecular weight markers. The recovery was 50-72% of total loaded IRG. Crystalline glucagon (Eli Lilly, Indianapolis, Indiana, USA) was loaded in control runs at two concentrations of 25 and 50 pg/ml (2.5 ml), eluting as IRG 35~176 84% and 94%, respectively.
Results
Laboratory Findings
Routine clinical parameters were within the normal range including serum levels of vitamin Bt2. Two hours after a 100g oral glucose load, blood glucose rose to 8.0 mmol/1 without late hypoglycaemia during the postabsorptive phase up to 5 h. After a starvation period of 28 h, she became clinically hypoglycaemic at a blood glucose level of 2.1 mmol/1. At this time insulin levels were appropriately suppressed, excluding an insulinoma (2.4-2.8 mU/1 compared with 5.0mU/1 after an overnight fast).
Basal levels of thyroxine (T4) were 3.6-4.3 p,g/dl (normal 5.0-14.0gg/dl), 3-iodothyronine (T3) 102-142 ng/dl (normal 60-200ng/dl), and gastrin 5 pg/ml Total IRG failed to increase appropriately during insulin-induced hypoglycaemia, and following an IV arginine load the IRG increase was 39% and 63% above basal levels on two different days compared with a 173% increase in normal subjects (Fig.l) . Basal, post-insulin and post-arginine plasmas (drawn before development of diabetes) were chromatographed for glucagon assay. During basal conditions, levels of IRG 35~176 were close to undetectable values (1-3pg/ml) with a questionable increase to 18 pg/ml during insulin-induced hypoglycaemia. After arginine administration IRG 35~176 increased to 109 pg/ml and IRG 9~176176 to 50 pg/ml (Fig.2) . In 18 normal subjects total IRG was 142_+ 12 pg/ml, IRG 35~176 amounting to 16 _+ 2 pg/ml. In one normal subject IRG 35~176 increased from 17 to 84 pg/ml during insulin-hypoglycaemia. The titre of thyroid microsomal antibodies (Wellcome Thymune'M'Kit) varied from 1:64,000 to 1: 102,000 during the 2.5-year period of observation and gastric parietal cell antibodies were constantly positive. Thyroglobulin antibodies (Wellcome Thymune'T'Kit) and antibodies to adrenal, pancreatic islet (either islet cell antibodies or specific glucagon or somatostatin cells), steroid and pituitary cells were constantly negative when tested by the indirect immunofluorescence technique using cryostat sections of the corresponding organs. The HLA determination was positive for HLA- B8, A1 and A3. The evaluation of serum amino acid levels after an overnight fast demonstrated moderate hyperaminoacidaemia; elevations of alanine (532 ~tmol/1), glycine (320 p.mol/1), serine (194 p.mol/1), arginine (142 p~mol/1) and ornithine (110 ~tmol/1) were detected, whereas the sum of branched chain amino acids (valine, leucine, isoleucine) was within the lower normal range (377 p.mol/1). The patient was discharged on thyroid hormone and hydrocortisone replacement therapy. After 2 months she was admitted to another hospital after weight loss of 7 kg with ketoacidosis and hyperglycaemia of 25.0 mmol/1 requiring constant insulin therapy. At that time, urinary C-peptide was 3.7 ~g/ 24 h and plasma C-peptide level was 0.19 ng/ml in the basal state.
Discussion
The case of a female patient suffering from recurrent fasting hypoglycaemia associated with combined lack A. A. R. Starke et al.: Glucagon Deficiency: Case Report of glucagon, cortisol and growth hormone before the development of Type I diabetes is reported. Besides primary hypothyroidism, she presented with partial hypopituitarism (lack of growth hormone and ACTH response to adequate stimuli) and adrenal insufficiency. The presence of blunted cortisol secretion at normal or even low basal and non-stimulatable ACTH levels clearly revealed dysfunction of both the adrenal and pituitary glands. There was no deterioration of the gonadal axis. The presence of autoantibodies against the thyroid gland and gastric parietal cells as well as HLA-B8 indicates a polyglandular failure syndrome of autoimmune pathogenesis. The disparity between findings of hormone deficiencies and the presence of autoantibodies in this syndrome is well known [7] . However, it is striking that islet cell antibody testing was constantly negative before the manifestation of diabetes, although the pathogenesis of diabetes in this patient seems most likely to be of autoimmune origin. After two years of diabetes, ICA were still negative. The fundamental contribution of glucagon to an appropriate glucose recovery from insulin-induced hypoglycaemia in normal subjects has been assessed during pharmacological glucagon deficiency by means of somatostatin infusions [10, 15] . There is strong evidence that adrenaline secretion acts as a secondary defense against hypoglycaemia in the case of impaired glucagon secretion, whereas cortisol and growth hormone do not seem to be of critical importance in acute glucose counter-regulation. In this patient, in contrast to normal individuals, we observed insufficient, only marginal release of true pancreatic glucagon in the basal state and during severe insulin induced hypoglycaemia. Although adrenaline data are not available, it is apparent that the adrenomedullary system did not compensate for the impaired glucagon response. Thus, the question arises if the failure of glucose recovery was the consequence of a lesion in the central nervous system as outlined in a case report by Boden [16] , or associated with the polyglandular failure syndrome as far as the adrenomedullary system is concerned. As thyroid hormone deficiency decreases the metabolism of various hormones (e.g., cortisol) without reducing production rates and cortisol deficiency is associated with increased glucagon levels [17] , it seems unlikely that hypothyroidism and adrenal insufficiency accounted for the inappropriate glucagon response. Nevertheless, an increase of IRG 35~176 after intravenous arginine was clearly demonstrated by chromatography. The development of diabetes could not account for the impaired glucagon response to hypoglycaemia (plasma samples for chromatography were drawn before onset of diabetes) as it was shown recently that the impaired glucagon response to hypoglycaemia is acquired in Type I diabetic patients with duration of the disease [18] .
The elevated serum levels of alanine, glycine, serine, arginine and ornithine were well in accordance with the deficiency of pancreatic glucagon as similar amino acid profiles have been shown in patients after pancreatectomy, when IRG 35~176 seemed to be completely or partially absent [19, 20] . However, normal serum branched chain amino acids were in accordance with the normal insulin levels assayed before onset of diabetes.
In summary, we believe that the fasting hypoglycaemia and the failure of glucose recovery following insulin-induced hypoglycaemia already present in this patient before the onset of diabetes was primarily due to glucagon deficiency. Apparently, the adrenomedullary system did not compensate for the impaired glucagon secretion. Although islet cell antibodies were constantly undetectable despite the development of diabetes in our patient with the polyglandular failure syndrome, it is hypothesized that glucagon deficiency may sometimes be part of the syndrome.
